Intellia Therapeutics Inc buy Chardan Capital
Start price
28.02.25
/
50%
€9.69
Target price
28.02.26
€65.29
Performance (%)
3.56%
Price
16.02.26
€10.04
Summary
This prediction is currently active. With a performance of 3.56%, the BUY prediction by Chardan_Capital for Intellia Therapeutics Inc is trending in the right direction. This prediction currently runs until 28.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -4.155% | -4.155% |
| iShares Core DAX® | 0.463% | -1.530% |
| iShares Nasdaq 100 | -1.792% | -5.385% |
| iShares Nikkei 225® | 5.124% | 8.053% |
| iShares S&P 500 | -1.760% | -3.821% |
Comments by Chardan_Capital for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Chardan Capital from $91.00 to $68.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€12.31
27.10.25
27.10.25
€41.25
27.10.26
27.10.26
-18.48%
16.02.26
16.02.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.60
09.05.25
09.05.25
€60.64
09.05.26
09.05.26
32.04%
16.02.26
16.02.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.46
18.11.24
18.11.24
€86.10
18.11.25
18.11.25
-46.48%
19.11.25
19.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.98
07.08.23
07.08.23
€97.28
07.08.24
07.08.24
-45.29%
08.08.24
08.08.24